Plasma homocysteine level and apathy in Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 59, Issue 9, 2011, Pages 1752-1754

  Chen, Cheng Sheng ^a,b   Yeh, Yi Chun ^a   Chang, Yu San ^c   Huang, Mei Feng ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c Kaohsiung Kai Suan Psychiatric Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; APATHY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APATHY; FEMALE; HOMOCYSTEINE; HUMANS; MALE; SEX FACTORS;

EID: 80054752337     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03550.x     Document Type: Letter

References (10)

1. Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483. (Pubitemid 34441738)
2. Seshadri S, Wolf PA, Beiser AS et al. Association of plasma total homocysteine levels with subclinical brain injury: Cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 2008;65:642-649. (Pubitemid 351679660)
3. Chen C-S, Kuo Y-T, Tsai H-Y et al. Brain biochemical correlates of the plasma homocysteine level: A proton magnetic resonance spectroscopy study in the elderly subjects. Am J Geriatr Psychiatry 2011;19:618-626.
4. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991;38:143-162.
5. Clarke DE, Reekum R, Simard M et al. Apathy in dementia: An examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci 2007;19:57-64. (Pubitemid 46294446)
6. Murphy DG, DeCarli C, McIntosh AR et al. Sex differences in human brain morphometry and metabolism: An in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 1996;53:585-594. (Pubitemid 26240861)
7. Treiber KA, Lyketsos CG, Corcoran C et al. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: The Cache County Study. Int Psychogeriatr 2008;20:538-553. (Pubitemid 351465551)
8. Hogervorst E, Ribeiro HM, Molyneux A et al. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002;59:787-793. (Pubitemid 34517761)
9. Lanctot KL, Herrmann N, Black SE et al. Apathy associated with Alzheimer disease: Use of dextroamphetamine challenge. Am J Geriatr Psychiatry 2008;16:551-557.
10. Benoit M, Clairet S, Koulibaly PM et al. Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. Int J Geriatr Psychiatry 2004;19:864-869. (Pubitemid 39242892)